MedPath

上海美优制药有限公司

Ownership
-
Established
1998-02-26
Employees
-
Market Cap
-
Website
www.meiyouzhiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

61

NMPA:61

Drug Approvals

Levetiracetam Oral Solution

Product Name
左乙拉西坦口服溶液
Approval Number
国药准字H20253954
Approval Date
Apr 22, 2025
NMPA

利福平胶囊

Approval Number
国药准字H31021971
Approval Date
Aug 15, 2024
NMPA

脑乐静

Approval Number
国药准字Z19993382
Approval Date
Aug 15, 2024
NMPA

五维他口服溶液

Approval Number
国药准字H31022343
Approval Date
Aug 15, 2024
NMPA

肌苷片

Approval Number
国药准字H31021970
Approval Date
Aug 15, 2024
NMPA

阿莫西林胶囊

Approval Number
国药准字H20003781
Approval Date
Aug 9, 2024
NMPA

头孢拉定胶囊

Approval Number
国药准字H31021618
Approval Date
Aug 9, 2024
NMPA

头孢克洛胶囊

Approval Number
国药准字H10970246
Approval Date
Aug 9, 2024
NMPA

对乙酰氨基酚滴剂

Approval Number
国药准字H31022913
Approval Date
Aug 9, 2024
NMPA

盐酸米诺环素胶囊

Approval Number
国药准字H10950348
Approval Date
Aug 9, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.